Groundbreaking Leukemia Treatment ‘a Entire Fresh Approach’ to Fighting Cancer FDA approves CAR T-cell therapy, a state-of-the-art immune-therapy trial to target childhood leukemia. Mott is poised to suggest the treatment — one of a select few sites in the country on track to do so. […]